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Objective:  To  examine  trends  in the  prevalence  of  problematic  cocaine  use  in a  large  city and  describe
the  problems  encountered  when  estimating  these  trends  using  capture-recapture  techniques  based  on
secondary  data
Methods: We  used  clinical  data  on accident  and  emergency  department  episodes  at four  university hos-
pitals  in  Barcelona  (Spain)  between  1999  and 2008  (3  capture  periods  per  year).  Users  were  categorized
into  two  subgroups  depending  on  concomitant  heroin  use  (cocaine  plus  heroin,  cocaine  without  heroin).
Results: The  mean  age  of users  was  34  years  and  25%  were  women  (2008).  The mean  number  of  episodes
per  user  differed  between  drug  subgroups  and  over  time.  The  estimated  total  number  of  cocaine  users
increased  from  6,028  (95%  conﬁdence  interval  [95%CI]:  4,086-9,327)  in  1999  to  22,640  (95%CI:  14,001-
37,500)  in  2006,  but  decreased  thereafter.  The  prevalence  of  problematic  use  of cocaine  plus  heroin  was
stable throughout  the  study.  Thus,  trends  in  the  prevalence  of  problematic  cocaine  use  differed  depending
on  concomitant  heroin  use.
Conclusion:  Our  results  are  consistent  with  those  provided  by  health  surveys  and treatment  registries.
They  also highlight  the  pitfalls  of applying  the  capture-recapture  approach  to  secondary  data,  and  the
need  for  a better  understanding  of how  information  is collected  and  changes  over time.
© 2015  SESPAS.  Published  by  Elsevier  España,  S.L.U.  All rights  reserved.
Estimación  de  la  tendencia  de  la  prevalencia  del  consumo  problemático
de  cocaína  (1999-2008)
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Objetivo:  Explorar  la  tendencia  de  la  prevalencia  del consumo  problemático  de  cocaína  en  una  gran
ciudad  y  describir  los problemas  encontrados  cuando  se estiman  estas  tendencias  mediante  técnicas  de
captura-recaptura  utilizando  datos  secundarios.
Métodos: Se utilizaron  los  datos de  los servicios  de  urgencias  de  cuatro  hospitales  universitarios  de
Barcelona  entre  1999  y 2008  (tres  capturas  por  an˜o).  Las  personas  se clasiﬁcaron  en  dos  subgrupos  según
el  uso  concomitante  de  heroína  (cocaína  junto  con  heroína,  cocaína  sin heroína).
Resultados:  La edad  media  fue de  34 an˜os  (2008)  y  el 25%  eran  mujeres.  El  número  medio  de  episodios
por  paciente  fue  distinto  según  el subgrupo  y el an˜o.  La  estimación  del  número  total  de consumidores/as
problemáticos/as  de  cocaína  aumentó  de 6028  (intervalo  de  conﬁanza  del  95% [IC95%]: 4086-9327)  en
1999  a 22.640  (IC95%:  14.001-37.500)  en  2006,  y disminuyó  a  partir  de  entonces.  La  prevalencia  del
consumo  problemático  de  cocaína  más  heroína  se  mantuvo  estable  durante  el período.  Por lo  tanto,  las
tendencias  de  prevalencia  diferían  dependiendo  del consumo  de  heroína  concomitante.
Conclusión:  Los  resultados  concuerdan  con  los  de  las  encuestas  de  salud  y con  los  registros  de  tratamiento.
Los resultados  también  ponen  de relieve  ciertos  peligros  en  la aplicación  de  la captura-recaptura  para
datos  secundarios,  y la  necesidad  de un conocimiento  profundo  de  cómo  se  recopila  la información  y los
posibles  cambios  en el tiempo.
5  SES© 201∗ Corresponding author.
E-mail address: adomingo@imim.es (A. Domingo-Salvany).
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IntroductionThe capture-recapture approach is an indirect method of ge-
nerating prevalence estimates based on the degree of overlap (the
appearance of a case/individual in more than one sample)1 between
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wo or more distinct samples of the study population, and has been
sed to estimate prevalence in many epidemiological scenarios,2
ncluding hard to reach populations3,4 such as illegal drug users.5
urveys designed to estimate the prevalence of illegal drug use have
he important limitation that illegal drug users are hard to detect
ecause they are a small fraction of the population and often con-
eal themselves due to the illegal and highly stigmatized nature of
rug-taking.6 Thus, the capture-recapture technique has been used
n distinct geographical areas, including cities of different sizes, to
stimate the prevalence of illegal drug use, mainly of opiates and
ocaine.5,7–10While capture-recapture has proven to be adequate
or estimating prevalence in incomplete epidemiological data,2,11
t involves certain assumptions: 1) the target population must be
losed; 2) false-positive subjects should not be present on any list;
) capture sources should be independent; and 4) each case in the
opulation should be equally likely to be captured in each source.11
n addition to these assumptions,11 this approach has other limita-
ions: the speciﬁc application of the method, especially when using
econdary data that is susceptible to changes in the data collection
rotocol, as well as on professional criteria in identifying relevant
haracteristics.12
Cocaine is one of the most widely used illegal drugs in Europe,
nd Spain has one of the highest prevalence rates.13 To assess the
onsequent burden on health care services and the need for pre-
entive interventions, it is important for public health ofﬁcials to
ave a clear picture of the magnitude of problematic cocaine use
nd trends in consumption.
The aim of this study was to examine trends in the prevalence of
roblematic cocaine use in Barcelona (Spain) through the capture-
ecapture approach based on a secondary data source, namely visits
o the city’s four main emergency rooms (ER). We  also describe
roblems encountered in applying this approach.
ethods
The Barcelona Drug Information System (SIDB) created in 1987
ollects information about ER at the city’s four university hos-
itals that involved patients aged 15-54 years, and where the
orresponding clinical record mentioned the use of illegal drugs.
 previous study found that these emergency rooms covered about
5% of drug-related emergencies in Barcelona14. We  selected visits
etween 1999 and 2008 involving Barcelona city residents who
isited the ER at least once in the year in question, with a me-
ical record mentioning cocaine. ER records do not always report
onsumed substances7, so we considered that all substances men-
ioned in the ER record(s) for each patient in a given year had been
sed by him/her throughout the year. Episodes for each individual
ere grouped using a conﬁdential identiﬁcation algorithm.
We collected data on age, gender, and drugs used. Data on drugs
sed were collected from clinical notes written by the physician.
ndividuals were categorized into two consumer proﬁles according
o their concomitant use of opioids (mainly heroin) in any episode
n a given year: either “cocaine plus heroin”, or “cocaine without
eroin”. A single source capture-recapture technique was applied
or each individual year 2,15 to estimate the prevalence of pro-
lematic cocaine use for the entire sample and separately for each
onsumer proﬁle, cocaine with heroin and cocaine without heroin.
We assumed that the prevalence did not vary within a given
alendar year. To assess possible sample dependences, the ER regis-
er for a full year was divided into three 4-month periods, and each
eriod was considered to be a distinct sample.5,7,16 To estimate
he unknown population, we ﬁtted log-linear regression models
or each year and each consumer proﬁle. To adjust for possible
ependencies between samples, we ﬁtted models with all possi-
le combinations of interactions (one, two or three interactions of015;29(5):353–357
two 4-month periods), and evaluated the best ﬁt using the Bayesian
Information Criterion (BIC).1,17 Models with a deviance of less
than ± 2 degrees of freedom were considered well-ﬁtted. When we
found more than one model with a good ﬁt, we computed the esti-
mate for the unknown population by averaging BIC-weighted
estimates from the adjusted models (the BIC-weighted estimates
were calculated using NˆwIC =
∑
(Nˆi · e−(ICi/2))/
∑
e−(ICi/2), where ICi
is the BIC information considered and N̂i is the population esti-
mate associated with each model i)18. When dependence between
the three capture periods was not rejected, we  ﬁtted the saturated
model to estimate the unknown population.11 Finally, 95% conﬁ-
dence intervals (95%CI) were calculated according to Cormack.15,19
All analyses were performed using STATA version 11 and R 2.8.
Results
Over the period of this study, we  observed an increase in the
number of patients who received emergency treatment with a
mention of cocaine in their medical record: from 1,282 in 1999
to 2,161 in 2008 (Table 1). This increase was statistically signiﬁcant
(p-value for trend <0.05) in patients who consumed cocaine with-
out heroin,  but not those who consumed cocaine with heroin.  The
number of emergency episodes also increased during this period,
from 2,235 in 1999 to 4,358 in 2008. The number of overlaps (when
an individual appears in more than one trimester) remained cons-
tant between 1999 and 2006, but increased in 2007 and 2008. The
mean proportion of patients in the cocaine with heroin and cocaine
without heroin groups who received emergency treatment once in a
year was  67.3% and 92.0% between 1999 and 2006, respectively, and
45.8% and 79.0% in 2007-2008. The percentage of female patients
remained constant at around 25%, while the average age of
patients increased over time in both groups (cocaine with heroin
and cocaine without heroin)  (Table 1).
The estimated annual prevalence of problematic cocaine
use is shown in Table 2. The estimated number of users in
Barcelona increased from 6,028 (95%CI: 4,086-9,327) in 1999 to
22,640 (95%CI: 14,009-37,500) in 2006, and decreased to 6,645 by
2008 (95%CI: 5,329-8,457), comparable to the initial rate in 1999.
The use of cocaine without heroin was the most common consumer
proﬁle, and its prevalence increased rapidly and then decreased
during the study period (1.21% in 1999, 2.93% in 2005, and 0.64% in
2008). In contrast, the prevalence of cocaine use with heroin was
lower and remained stable during the study period (0.10% in 1999,
0.15% in 2005 and 0.09% in 2008).
Discussion
The prevalence of problematic cocaine use in the city of
Barcelona increased between 1999 and 2006, and decreased rapidly
in the following two years; in contrast, the number of emergency
room visits involving cocaine use increased continuously during
this period. This prevalence trend differed between the two con-
sumer proﬁles analyzed, remaining stable in the cocaine plus heroin
group, and following the overall trends described above in the
cocaine without heroin.
A strength of the study is the fact that the prevalence of
problematic cocaine use was  estimated in a large sample from
a well-deﬁned geographical area over a period of several years,
and using the same capture-recapture approach with the same
source of information. Overall trends (including conﬁdence inter-
vals) for the period 1999-2006 are consistent with those reported
by other studies using indirect indicators (treatment demand data
and mortality) in Barcelona,20,21 and with others in Spain and
other European countries.13,22 However, the decrease observed
after 2006 was unexpected, especially given the increase in the
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Table  1
Characteristics of patients visited in hospital emergency rooms with a mention of cocaine use on their medical record. Barcelona, 1999-2008.
Patients attended Gender Age Episodes Three overlaps Two overlaps One  overlap
N  (% women) (Mean age) N % % %
Cocaine without heroin
1999 735 27.2 30.10 936 1.0 8.2 90.9
2000  764 27.4 30.31 1,030 1.0 7.5 91.5
2001 691 26.7 29.93 874 0.4 7.7 91.9
2002 858 25.4 29.89 1,064 0.6 5.8 93.6
2003 963 24.0 31.25 1,202 1.1 7.1 91.8
2004 1,134 27.1 31.08 1,442 0.7 7.1 92.2
2005 1,321 24.5 31.43 1,662 1.0 7.6 91.4
2006 1,262 25.8 31.93 1,623 1.3 6.3 92.3
2007 1,397 25.3 33.18 2,053 3.0 17.0 80.0
2008  1,526 25.2 33.21 2,521 3.5 18.5 78.0
p-value for trend <0.05 >0.05 <0.05 <0.05 <0,05 <0,05 <0,05
Cocaine with heroin
1999 547 25.2 31.01 1,299 7.7 29.4 62.9
2000  567 20.3 30.69 1,315 5.8 29.5 64.7
2001 566 21.0 31.43 1,277 5.5 28.1 66.4
2002 625 23.1 32.26 1,455 7.2 24.6 68.2
2003 573 19.7 32.48 1,199 5.4 25.7 68.9
2004 476 20.6 33.97 1,062 5.9 23.7 70.4
2005 501 24.0 34.31 1,163 6.2 23.8 70.1
2006 433 22.9 34.57 1,002 7.4 25.9 66.7
2007 649 23.1 35.27 2,026 11.9 40.4 47.8
2008 635 24.4 35.81 1,837 19.5 36.5 43.9
p-value for trend >0.05 >0.05 <0.05 >0.05 <0,05 >0,05 >0,05
Total
1999  1,282 26.4 30.49 2,235 3.8 17.2 78.9
2000  1,331 24.3 30.47 2,345 3.1 16.8 80.1
2001 1,257 24.1 30.60 2,151 2.7 16.9 80.4
2002 1,483 24.4 30.89 2,519 3.4 13.8 82.9
2003 1,536 22.4 31.71 2,401 2.7 14.0 83.3
2004 1,610 25.2 31.94 2,504 2.2 12.0 85.8
2005 1,822 24.3 32.23 2,825 2.4 12.0 85.6
2006 1,695 25.0 32.60 2,625 2.9 11.3 85.8
2007 2,046 24.6 33.85 4,079 5.8 24.4 69.8
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p-value for trend <0.05 >0.05 <0.05 
umber of emergency episodes in which cocaine was  mentioned
n the medical record. In considering the possible reasons for this
ecrease, we observed that the magnitude and conﬁdence intervals
f the estimates were affected by an increase in the mean number of
pisodes per person in 2007-2008. Capture-recapture is very sen-
itive to changes in the number of overlaps, which may  cause over-
nd underestimation.1 In epidemiological studies these changes
ay  derive from data collection patterns. While we  were not able
o test the inﬂuence of contextual changes that occurred during the
tudy period on trends in problematic cocaine use, our results could
e partly due to increased access to emergency rooms or changes
n how the patients are registered. In our case, the increasing mean
umber of episodes per person, and thus of overlaps, is probably
ue to changes in physicians’ awareness of cocaine use in emer-
ency situations and its report. The increasing mean number of
pisodes per person is especially relevant when few overlaps are
resent.
Furthermore, stratifying the analysis into two consumer proﬁle
ubgroups, the trend among users of both heroin and cocaine
irrored the stable pattern of heroin use in the city, whereas the
stimated prevalence of consumers of cocaine without heroin had
ide conﬁdence intervals and an unexpected trend over time.
stimates for the cocaine with heroin group are stable because of
he high number of overlaps during the study period (more than
0% of the sample); the increase in the number of episodes was
robably prompted by their physical problems and stigma.12,23
he low proportion of repeated episodes in the cocaine without
eroin group (<10% of overlaps before 2007, and 20% thereafter)
esulted in unstable estimates, and prevented us from generating4,358 8.2 23.8 68.0
<0.05 >0,05 >0,05 >0,05
an estimate for one of the study years (2006). The observed
increase in the number of overlaps could also be an artifact related
to changes either in some aspects of the population (e.g., health
status, patterns of use) or in health services available, although they
seem unlikely to be important, according to published information
on the city’s health services.
Another possible limitation is users’ tendency to underreport
cocaine use when attending the ER,12,24–26 and we  attempted
to minimize this bias by considering all substances mentioned
by individuals in a given year. While this underreporting might
differentially affect the two  consumer proﬁle subgroups studied,
probably with a greater impact in the cocaine without heroin sub-
group, the epidemiological curve would not be greatly affected if
underreporting remained constant over time. In addition, consi-
dering only ER data is another possible cause of underreport-
ing, as reported previously.5 Other possible limitations include
assumptions of the capture-recapture approach, as reported in
other studies11, and to the fact that we cannot account for various
confounding variables (e.g., socioeconomic variables) that could
inﬂuence the prevalence trend. Further studies should focus on this
topic. Finally, it was  only possible to analyze data from 1999 to 2008
because more recent data were not available. However, the 10-year
trend observed was  relevant per se, as discussed above.
Trends in the prevalence of cocaine use may  differ depending on
whether or not other drugs were used concomitantly (e.g., heroin
in the present study). Our results also highlight some of the dangers
involved in applying the capture-recapture approach to secondary
data, in that a considerable number of samples’ overlaps is needed,
and contextual changes may  lead to signiﬁcant variation in the type
356 A. Espelt et al. / Gac Sanit. 2
Table 2
Estimated prevalence of problematic cocaine use by subgroup and year. Barcelona,
1999-2008.
Number of users Population
prevalencea
Known Estimated 95%CI Estimate 95%CI
1999
Cocaine
without heroin
735 10,082 3,735-28,059 1.21 0.45-3.38
Cocaine with
heroin
547 822 724-973 0.10 0.09-0.12
Total 1,282 6,028 4,086-9,327 0.73 0.49-1.24
2000
Cocaine
without heroin
764 16,320 5,898-46,413 1.96 0.71-5.59
Cocaine with
heroin
567 762 755-905 0.09 0.09-0.11
Total 1,331 5,754 3,920-8,867 0.69 0.47-1.07
2001
Cocaine
without heroin
691 3,116 2,394-7,459 0.37 0.28-0.88
Cocaine with
heroin
566 1,052 875-1,345 0.12 0.10-0.16
Total 1,257 5,258 3,511-8,331 0.62 0.42-0.99
2002
Cocaine
without heroin
858 21,975 6,528-66,422 2.56 0.76-7.75
Cocaine with
heroin
625 1,660 1,167-2,610 0.19 0.14-0.30
Total 1,483 13,211 8,357-21,611 1.54 0.97-2.52
2003
Cocaine
without heroin
963 31,960 12,279-86,260 3.67 1.41-9.90
Cocaine with
heroin
573 1,204 974-1,590 0.14 0.11-0.18
Total 1,536 12,290 7,717-20,336 1.41 0.89-2.33
2004
Cocaine
without heroin
1,134 21,128 8,227-54,433 2.39 0.93-6.16
Cocaine with
heroin
476 1,172 895-1,681 0.13 0.10-0.19
Total 1,610 17,304 10,390-29,773 1.96 1.18-3.37
2005
Cocaine
without heroin
1,321 26,581 12,007-59,567 2.93 1.32-6.57
Cocaine with
heroin
501 1,362 911-2,317 0.15 0.10-0.26
Total 1,822 19,227 12,063-31,490 2.12 1.33-3.47
2006
Cocaine
without heroin
1,262 -b - - -
Cocaine with
heroin
433 955 678-1,543 0.11 0.07-0.17
Total 1,695 22,640 14,009-37,500 2.50 1.54-4.13
2007
Cocaine without
heroin
1,397 3,017 2,193-4,398 0.34 0.25-0.49
Cocaine with
heroin
649 778 714-874 0.09 0.08-0.10
Total 2,046 3,220 2,956-3,537 0.36 0.33-0.40
2008
Cocaine
without heroin
1,526 5,765 4,138-8,403 0.64 0.46-0.93
Cocaine with
heroin
638 809 747-892 0.09 0.08-0.10
Total 2,161 6,645 5,329-8,457 0.73 0.59-0.93
95%CI: 95% conﬁdence interval.
a Prevalence per 100 inhabitants 15–54 years old.
b Estimates not possible.015;29(5):353–357
of information gathered in clinical records. Relying on secondary
data to assess basic epidemiological indicators requires a thorough
understanding of how this information is collected and of changes
in the data collection procedure over time.
What is known about the topic?
Capture-recapture is a widely used method to estimate
prevalence of hidden populations. In Spain, the cocaine use
epidemic followed a large epidemic of heroin use and, in fact,
its increase overlapped with a decrease in the heroin use epi-
demic.
What does this study add to the literature?
The prevalence of problematic cocaine use increased
steadily up to 2006, after which it appeared to decline. Cocaine
prevalence trends may differ depending on concomitant drug
use. Contextual changes may lead to relevant variations in the
information gathered in clinical records, affecting prevalence
estimates. In capture-recapture, a certain amount of overlap
between samples is needed to avoid results being inconsistent.
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